John Byrd: So great to be together with these great friends who have a passion for developing new therapies and caring for patients with CLL.

John Byrd, Chair at the Department of Internal Medicine, University of Cincinnati College of Medicine, shared on LinkedIn:

“Last weekend many of us were together at the International Workshop in CLL in Boston. Pictured here is Drs. Deborah Stephens, Jeff Sharman, Kanti Rai and myself. So great to be together with these great friends who have a passion for developing new therapies and caring for patients with CLL. Also so exciting to hear Dr. Molica’s presentation that CLL patients requiring therapy who went onto Bruton’s tyrosine kinase inhibitors (acalabrutinib and ibrutinib) have a survival similar to the age and sex match control population.”

Source: John Byrd/LinkedIn